Scoop: Gilead’s CAR-T player Kite waves goodbye to research chief Peter Emtage as another top exec hits the exit

John Carroll

Editor & Founder

Endpoints News has learned that Peter Emtage, the head of research at Gilead CAR-T subsidiary Kite, is leaving the company at the end of this month.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

Scoop: Gilead’s CAR-T player Kite waves goodbye to research chief Peter Emtage as another top exec hits the exit

John Carroll

Editor & Founder

Unlock this article instantly by becoming a free subscriber.

Drug and biotech companies join lobbying push on China bill as scrutiny of WuXi continues

Roche unruffled by China bill as it looks to grow roots in the region

FDA's biologics chief Peter Marks previews accelerated approval guidance

Cancer testing company Freenome to lay off 100 employees

Roche doubles down on high-impact projects after slashing 20% of its pipeline

Following lower-than-expected profits, Evotec plans to cut costs, completes CEO search

Scoop: Gilead’s CAR-T play­er Kite waves good­bye to re­search chief Pe­ter Em­tage as an­oth­er top ex­ec hits the ex­it

John Carroll

Editor & Founder

Unlock this article instantly by becoming a free subscriber.

more like this

Drug and biotech com­pa­nies join lob­by­ing push on Chi­na bill as scruti­ny of WuXi con­tin­ues

Roche un­ruf­fled by Chi­na bill as it looks to grow roots in the re­gion

FDA's bi­o­log­ics chief Pe­ter Marks pre­views ac­cel­er­at­ed ap­proval guid­ance

Can­cer test­ing com­pa­ny Freenome to lay off 100 em­ploy­ees

Roche dou­bles down on high-im­pact projects af­ter slash­ing 20% of its pipeline

Fol­low­ing low­er-than-ex­pect­ed prof­its, Evotec plans to cut costs, com­pletes CEO search

Scoop: Gilead’s CAR-T player Kite waves goodbye to research chief Peter Emtage as another top exec hits the exit

Drug and biotech companies join lobbying push on China bill as scrutiny of WuXi continues

Roche unruffled by China bill as it looks to grow roots in the region

FDA's biologics chief Peter Marks previews accelerated approval guidance

Cancer testing company Freenome to lay off 100 employees

Roche doubles down on high-impact projects after slashing 20% of its pipeline

Following lower-than-expected profits, Evotec plans to cut costs, completes CEO search